{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T05:42:03Z","timestamp":1792129323247,"version":"4.4.0"},"reference-count":19,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["M\u00e9decine et Maladies Infectieuses"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.medmal.2017.07.001","type":"journal-article","created":{"date-parts":[[2017,8,7]],"date-time":"2017-08-07T14:03:10Z","timestamp":1502114590000},"page":"477-483","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":93,"title":["Antibiotic susceptibility of probiotic strains: Is it reasonable to combine probiotics with antibiotics?"],"prefix":"10.1016","volume":"47","author":[{"given":"C.","family":"Neut","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Mahieux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.J.","family":"Dubreuil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.medmal.2017.07.001_bib0100","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1093\/jac\/47.1.43","article-title":"Frequency of antibiotic-associated diarrhoea in 2462 antibiotic-treated hospitalized patients: a prospective study","volume":"47","author":"Wistr\u00f6m","year":"2001","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.medmal.2017.07.001_bib0105","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1159\/000016879","article-title":"Epidemiology, risk factors and treatments for antibiotic-associated diarrhea","volume":"16","author":"McFarland","year":"1998","journal-title":"Dig Dis"},{"key":"10.1016\/j.medmal.2017.07.001_bib0110","series-title":"Les antibiotiques les effets ind\u00e9sirables et les Fran\u00e7ais. Une enqu\u00eate IPSOS","author":"Ropion","year":"2015"},{"key":"10.1016\/j.medmal.2017.07.001_bib0115","doi-asserted-by":"crossref","first-page":"563","DOI":"10.2217\/17460913.3.5.563","article-title":"Antibiotic-associated diarrhea: epidemiology, trends and treatment","volume":"3","author":"McFarland","year":"2008","journal-title":"Future Microbiol"},{"key":"10.1016\/j.medmal.2017.07.001_bib0120","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1097\/00004836-200603000-00017","article-title":"Probiotics for the prevention of antibiotic-associated diarrhea and Clostridium difficile diarrhea","volume":"40","author":"Katz","year":"2006","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.medmal.2017.07.001_bib0125","doi-asserted-by":"crossref","first-page":"4212","DOI":"10.1172\/JCI72333","article-title":"Antibiotics and the gut microbiota","volume":"124","author":"Modi","year":"2014","journal-title":"J Clin Invest"},{"key":"10.1016\/j.medmal.2017.07.001_bib0130","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1038\/nrgastro.2014.66","article-title":"Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic","volume":"11","author":"Hill","year":"2014","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.medmal.2017.07.001_bib0135","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1097\/MPG.0000000000001081","article-title":"Probiotics for the prevention of antibiotic-associated diarrhea in children","volume":"62","author":"Szajewska","year":"2016","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.medmal.2017.07.001_bib0140","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1089\/mdr.2015.0328","article-title":"Microbiological cuttoff values: a critical issue in phenotypic antibiotic resistance assessment of Lactobacilli and bifidobacteria","volume":"22","author":"Polka","year":"2016","journal-title":"Microbial Drug resistance"},{"key":"10.1016\/j.medmal.2017.07.001_bib0145","series-title":"Antimicrobial susceptibility testing (v 4.0)","author":"European Committee on Antimicrobial Susceptibility Testing","year":"2014"},{"key":"10.1016\/j.medmal.2017.07.001_bib0150","series-title":"Methods for antimicrobial susceptibility testing of anaerobic bacteria; approved standard","author":"Clinical and Laboratory Standards Institute","year":"2007"},{"key":"10.1016\/j.medmal.2017.07.001_bib0155","series-title":"Breakpoint tables for interpretation of MICs and zone diameters, version 5.0","author":"European Committee on Antimicrobial Susceptibility Testing","year":"2015"},{"key":"10.1016\/j.medmal.2017.07.001_bib0160","series-title":"Antibiotics in laboratory medicine","year":"1986"},{"key":"10.1016\/j.medmal.2017.07.001_bib0165","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.foodres.2014.01.025","article-title":"Antibiotic resistance among commercially available probiotics","volume":"57","author":"Sharma","year":"2014","journal-title":"Food Res Int"},{"issue":"Suppl. 2","key":"10.1016\/j.medmal.2017.07.001_bib0170","doi-asserted-by":"crossref","first-page":"S116","DOI":"10.1093\/cid\/cis337","article-title":"Fidaxomicin attains high fecal concentrations with minimal plasma concentrations following oral administration in patients with Clostridium difficile infection","volume":"55","author":"Sears","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.medmal.2017.07.001_bib0175","doi-asserted-by":"crossref","first-page":"547","DOI":"10.3109\/00365548809032504","article-title":"Impact of cefixime on the normal intestinal microflora","volume":"20","author":"Nord","year":"1988","journal-title":"Scand J Infect Dis"},{"issue":"Suppl. 2","key":"10.1016\/j.medmal.2017.07.001_bib0180","doi-asserted-by":"crossref","first-page":"S85","DOI":"10.1093\/cid\/civ054","article-title":"From yaks to yogurt: the history, development, and current use of Probiotics","volume":"60","author":"McFarland","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.medmal.2017.07.001_bib0185","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1017\/S0954422410000090","article-title":"The probiotic paradox: live and dead cells are biological response modifiers","volume":"23","author":"Adams","year":"2010","journal-title":"Nutr Res Rev"},{"key":"10.1016\/j.medmal.2017.07.001_bib0190","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1179\/1973947813Y.0000000078","article-title":"Probiotics and clinical effects: is the number what counts?","volume":"25","author":"Bertazzoni","year":"2013","journal-title":"J Chemother"}],"container-title":["M\u00e9decine et Maladies Infectieuses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0399077X16307764?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0399077X16307764?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T01:15:55Z","timestamp":1759972555000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0399077X16307764"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":19,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["S0399077X16307764"],"URL":"https:\/\/doi.org\/10.1016\/j.medmal.2017.07.001","relation":{},"ISSN":["0399-077X"],"issn-type":[{"value":"0399-077X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antibiotic susceptibility of probiotic strains: Is it reasonable to combine probiotics with antibiotics?","name":"articletitle","label":"Article Title"},{"value":"M\u00e9decine et Maladies Infectieuses","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.medmal.2017.07.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}